Vitamin D Testing Market - Drivers and Forecasts by Technavio

Technavio has published a new report on the global vitamin D testing market from 2017-2021. (Graphic: Business Wire)

???pagination.previous??? ???pagination.next???

LONDON--()--Technavio analysts forecast the global vitamin D testing market to grow at a CAGR of around 5% during the forecast period, according to their latest report.

The research study covers the present scenario and growth prospects of the global vitamin D testing market for 2017-2021. Vitamin D testing market includes 25-Hydroxy vitamin D test and 1,25-Dihydroxy vitamin D test. These determine the proportion of vitamin D in the blood and serum.

25-Hydroxy vitamin D, which is also known as Calcifediol, is produced in the kidney from hydroxylation of vitamin D3. In vitamin D testing, it works as a biomarker, which helps to identify the bone health-related status. Similarly, Calcitriol, which is also known as 1,25-dihydroxycholecalciferol or 1,25-Dihydroxy vitamin D3, is produced in the nephrons of the kidneys.

This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

Technavio analysts highlight the following three factors that are contributing to the growth of the global vitamin D testing market:

Increase in number of vitamin D deficiency disorders

Vitamin D is associated with major health disorders such as diabetes, kidney disorder, cancer, nutritional rickets, obesity, heart disease, and orthopedic issue. Worldwide, there is an increase in the number of obesity and diabetes cases. According to OECD, in 2014, 18% of the total adult population and children were obese, especially in countries such as Mexico, New Zealand, the US, Canada, Chile, Australia, and England.

The incidence of obesity and diabetes leads to heart disease, which is a leading cause of death in many countries. Vitamin D has a critical role in calcium metabolism. Therefore, its deficiency leads to bone tenderness, calcium shortage, bone fracture, and back pain.

M&A of hospitals and diagnostic laboratories for better healthcare model

Srinivas Sashidhar, a lead in-vitro diagnostics research analyst at Technavio, says, “The growing acquisition and collaboration of hospitals drive the growth of the global vitamin D testing market. As large hospitals continue to acquire or merge with medium and small hospitals, the quality of the laboratory tests performed in these hospital labs will enhance due to the increase in the number of skilled professionals.”

The M&A of larger hospitals helps the labs with more capital investment and advanced technological infrastructure. With the increasing number of M&A and a large number of insured people, the number of patients undergoing treatment is rising, which, in turn, increases the number of clinical tests.

Increasing partnership and collaboration activities

The global vitamin D testing market is saturated with the presence of many vendors. So, it becomes necessary to maintain the market share in a competitive environment. Therefore, strategic alliance, such as partnership agreement, sales agreement, or distributions agreement, is crucial for surviving in the market.

The collaboration between small and medium-sized clinical diagnostic laboratories with government and large hospitals helps them to sustain in the market and also increases the number of procedures conducted. It also assists in advancing laboratory technologies and increasing market investments,” says Srinivas.

Top vendors:

  • F. Hoffmann-La Roche
  • Abbott
  • Siemens Healthineers

Browse Related Reports:

Become a Technavio Insights member and access all three of these reports for a fraction of their original cost. As a Technavio Insights member, you will have immediate access to new reports as they’re published in addition to all 6,000+ existing reports covering segments like oncology, vaccines, and cardiovascular devices. This subscription nets you thousands in savings, while staying connected to Technavio’s constant transforming research library, helping you make informed business decisions more efficiently.

About Technavio

Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.

Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, re-sellers, and end-users.

If you are interested in more information, please contact our media team at media@technavio.com.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770
www.technavio.com

Release Summary

Technavio analysts forecast the global vitamin D testing market to grow at a CAGR of around 5% during the forecast period, 2017-2021.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770
www.technavio.com